Literature DB >> 7609080

Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence.

A M Whatmore1, N Cook, G A Hall, S Sharpe, E W Rud, M P Cranage.   

Abstract

Experimental evidence from the simian immunodeficiency virus (SIV) model of AIDS has shown that the nef gene is critical in the pathogenesis of AIDS. Consequently, nef is of considerable interest in both antiviral drug and vaccine development. Preliminary findings in two rhesus macaques indicated that a deletion of only 12 bp found in the overlapping nef/3' long terminal repeat (LTR) region (9501 to 9512) of the SIVmacC8 molecular clone was associated with reduced virus isolation frequency. We show that this deletion can be repaired in vivo by a sequence duplication event and that sequence evolution continues until the predicted amino acid sequence of the repair is virtually indistinguishable from that of the virulent wild type. These changes occurred concomitantly with reversion to virulence, evidenced by a high virus isolation frequency and load, decline in anti-p27 antibody, substantial reduction in the CD4/CD8 ratio, and development of opportunistic infections associated with AIDS. These findings clearly illustrate the capacity for repair of small attenuating deletions in primate lentiviruses and also strongly suggest that the region from 9501 to 9512 in the SIV nef/3' LTR region is of biological relevance. In addition, the ability of attenuated virus to revert to virulence raises fundamental questions regarding the nature of superinfection immunity.

Entities:  

Mesh:

Year:  1995        PMID: 7609080      PMCID: PMC189330          DOI: 10.1128/JVI.69.8.5117-5123.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Mutational analysis of the human immunodeficiency virus: the orf-B region down-regulates virus replication.

Authors:  P A Luciw; C Cheng-Mayer; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

3.  Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity.

Authors:  E Terwilliger; J G Sodroski; C A Rosen; W A Haseltine
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

Review 5.  The role of Nef in the replication cycle of the human and simian immunodeficiency viruses.

Authors:  B R Cullen
Journal:  Virology       Date:  1994-11-15       Impact factor: 3.616

6.  A reliable method for the recovery of DNA fragments from agarose and acrylamide gels.

Authors:  G Dretzen; M Bellard; P Sassone-Corsi; P Chambon
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

7.  HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product.

Authors:  B Guy; M P Kieny; Y Riviere; C Le Peuch; K Dott; M Girard; L Montagnier; J P Lecocq
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

8.  The 3'-orf protein of human immunodeficiency virus shows structural homology with the phosphorylation domain of human interleukin-2 receptor and the ATP-binding site of the protein kinase family.

Authors:  K P Samuel; A Seth; A Konopka; J A Lautenberger; T S Papas
Journal:  FEBS Lett       Date:  1987-06-22       Impact factor: 4.124

9.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo.

Authors:  J Rose; P Silvera; B Flanagan; P Kitchin; N Almond
Journal:  J Virol Methods       Date:  1995-02       Impact factor: 2.014

View more
  55 in total

1.  In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.

Authors:  G Marzio; K Verhoef; M Vink; B Berkhout
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 2.  HIV-1 evolution: frustrating therapies, but disclosing molecular mechanisms.

Authors:  Atze T Das; Ben Berkhout
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

3.  Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication.

Authors:  Atze T Das; Bep Klaver; Alex Harwig; Monique Vink; Marcel Ooms; Mireille Centlivre; Ben Berkhout
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

4.  Evolutionary reconstruction of a hairpin deleted from the genome of an RNA virus.

Authors:  R C Olsthoorn; J van Duin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.

Authors:  E Khatissian; V Monceaux; M C Cumont; M P Kieny; A M Aubertin; B Hurtrel
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated Nef.

Authors:  E T Sawai; M S Hamza; M Ye; K E Shaw; P A Luciw
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef.

Authors:  Shailendra K Saxena; Gaurav Shrivastava; Sneham Tiwari; Ml Arvinda Swamy; Madhavan Pn Nair
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

8.  Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials.

Authors:  Scott A Brown; Sherri L Surman; Robert Sealy; Bart G Jones; Karen S Slobod; Kristen Branum; Timothy D Lockey; Nanna Howlett; Pamela Freiden; Patricia Flynn; Julia L Hurwitz
Journal:  Viruses       Date:  2010-02-01       Impact factor: 5.048

9.  Limited protection from a pathogenic chimeric simian-human immunodeficiency virus challenge following immunization with attenuated simian immunodeficiency virus.

Authors:  M G Lewis; J Yalley-Ogunro; J J Greenhouse; T P Brennan; J B Jiang; T C VanCott; Y Lu; G A Eddy; D L Birx
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Conservation of Nef function across highly diverse lineages of SIVsmm.

Authors:  Jan Schmökel; Hui Li; Elizabeth Bailes; Michael Schindler; Guido Silvestri; Beatrice H Hahn; Cristian Apetrei; Frank Kirchhoff
Journal:  Retrovirology       Date:  2009-04-09       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.